Extended Data Table 3 Estimated mean percent reduction in body weight, weight loss (kg) and change in body mass index from randomization (week 0) and from baseline (week −4) to week 24 in the intention-to-treat population including comparisons with early responders who were not randomized to a medication condition

From: Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial

  1. Data are estimated marginal means (±s.e.) for the intention-to-treat population (n = 131) derived from linear mixed models (two-sided α = 0.05). BT, behavioral treatment; AOM, anti-obesity medication (phentermine = 15.0 mg d−1).
Back to article page